Niaid.nih.gov View info health, medical, doctor

Microsoft Advertising Formerly Bing Ads

Details: Do you own niaid.nih.gov? You're Missing Out on High Value Audience with Lower Cost-per-Click & Great ROI! Get Started Today.

› Verified 7 days ago

› Url: Go.microsoft.com Go Now

› Get more:  HealthGo Now

Funding for Research on the Uptake of Health Interventions

Details: To help bridge the gap, these FOAs support research to identify, develop, and/or test strategies to overcome barriers to dissemination and implementation (D&I) of evidence-based interventions into public health, clinical practice, and community settings. In addition, or instead, you may study circumstances that create a need to stop or reduce

› Verified 9 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Minority Health & Health Disparities NIH: National …

Details: Health disparities are gaps in the quality of health and health care that mirror differences in socioeconomic status, racial and ethnic background, and education level. These disparities may stem from many factors, including accessibility of health care, increased risk of disease from occupational exposure, and increased risk of disease from underlying genetic, ethnic, or …

› Verified 2 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Let’s Talk—Global Health Careers NIH: National Institute …

Details: Global health is an interdisciplinary field focusing on improving health outcomes for people across the world. Read the latest edition of “Let’s Talk” where NIAID postbac Page Murray recaps the insights shared by the panelists and their career advice for NIAID postbacs. The panelists began by sharing what inspired their global health careers.

› Verified 3 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Diseases and Conditions

Details: More than 80 diseases occur as a result of the immune system attacking the body’s own organs, tissues, and cells. Some of the more common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. Treatments are available for many autoimmune diseases, but cures have yet to

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Food Allergy Is Associated with Lower Risk of SARS-CoV …

Details: A National Institutes of Health-funded study has found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them. In addition, while previous research identified obesity as a risk factor for severe COVID-19, the new study has identified obesity and high body mass index (BMI) as …

› Verified 3 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Infectious Diseases NIH: National Institute of Allergy and …

Details: Infectious Diseases. Infectious diseases have a wide variety of causes, and NIAID supports research to control and prevent diseases caused by virtually all human infectious agents. NIAID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, pre-clinical development, and clinical evaluation.

› Verified 4 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Overview of the Immune System NIH: National Institute …

Details: The immune system can distinguish between normal, healthy cells and unhealthy cells by recognizing a variety of "danger" cues called danger-associated molecular patterns (DAMPs). Cells may be unhealthy because of infection or because of cellular damage caused by non-infectious agents like sunburn or cancer. Infectious microbes such as viruses

› Verified 7 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  CancerGo Now

Anthony S. Fauci, M.D. NIH: National Institute of Allergy …

Details: Dr. Fauci is the director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health. He oversees an extensive portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis, and malaria as well as …

› Verified 4 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIH Begins Clinical Trial Evaluating Second COVID-19 Booster …

Details: A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. The trial aims to understand if different vaccine regimens—prototype and variant vaccines alone and in combinations—can broaden immune responses in adults who already have received a primary vaccination series and a …

› Verified 1 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Identify Challenges and Opportunities in Health and Science

Details: NIH seeks input from the broader scientific research community on effective health communication research through the Request for Information (RFI): Challenges and Opportunities in Health and Science Communication Research.. NIH hopes to identify important research opportunities, challenges, methods, approaches, and technologies to enable the …

› Verified 8 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIAID Scientist— Oral Virology (Ph.D. or M.D. required)

Details: The Viral Oral Infections in Immunosuppression and Cancer (VOIICe) is seeking a highly ambitious, adaptable, and detail-oriented scientist to join our vibrant team at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID).

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  CancerGo Now

Dr. Joseph Kinyoun—Overview NIH: National Institute of Allergy …

Details: In 1887, Dr. Joseph James Kinyoun founded the Hygienic Laboratory, from which the National Institutes of Health (NIH) evolved. This Web portal explores the fascinating life story of Joe Kinyoun, the acknowledged Father of NIH, and the crucible of social, scientific, and political forces during his time that were associated with the dawn of the microbial era in the United …

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Monkeypox NIH: National Institute of Allergy and Infectious …

Details: Initial symptoms of monkeypox infection include: fever, headache and body aches, fatigue, and swollen lymph nodes, followed by a rash of lesions on the skin. Human-to-human transmission of monkeypox occurs through direct contact with body fluids, lesions, prolonged face-to-face contact, and indirect contact with contaminated clothing or bedding.

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Staff Scientist (Clinical)

Details: The NIAID Centralized Sequencing Program (CSP) is a comprehensive program that obtains genetic testing, harmonizes phenotypic and genomic data, performs variant interpretation, and provides clinically validated results for patients enrolled in a diverse set of protocols at the National Institutes of Health (NIH) Clinical Center.

› Verified 1 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Health Scientist (Bioinformatics) Division of AIDS NIH: National

Details: The health scientist will be responsible for the overall programmatic responsibility for bioinformatics and data science/management as well as advanced technology efforts throughout the division, providing input for the strategic and tactical planning, development, and adaptation of new, related technologies and similar activities.

› Verified Just Now

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIAID Director Fauci Tests Positive for COVID-19

Details: Today, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Chief Medical Advisor to President Biden, tested positive for COVID-19 on a rapid antigen test. He is fully vaccinated and has been boosted twice. He is currently experiencing mild symptoms. Dr. Fauci will isolate and …

› Verified 2 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  MedicalGo Now

Monkeypox Vaccines NIH: National Institute of Allergy and …

Details: The JYNNEOS (Imvamune or Imvanex) vaccine, made by Bavarian Nordic A/S, is approved in Canada, Europe, and the United States for the prevention of smallpox and monkeypox. The JYNNEOS vaccine features an attenuated (weakened) form of live vaccinia virus that is incapable of replicating. NIAID provided significant support in the development of …

› Verified 4 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  CanadaGo Now

Coronavirus Vaccines and Prevention NIH: National Institute of

Details: In January 2020, as reports of the serious nature of SARS-CoV-2, the virus that causes COVID-19, began to emerge, NIH and Moderna agreed to collaborate and jointly develop a COVID-19 vaccine. The result was the COVID-19 vaccine now known as mRNA-1273 or Spikevax. By mid-March 2020, NIAID had begun enrollment in a Phase 1 clinical trial of the

› Verified 7 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Diseases Disproportionately Affecting Minorities

Details: The following are examples of health disparities related to infectious diseases and diseases of the immune system: Asthma. In 2015, approximately 2.2 million Hispanics/Latinos in the United States reported having asthma, and Puerto Rican Americans have almost three times the asthma rate of the overall Hispanic population.

› Verified 3 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

SARS-CoV-2 and NIAID-supported Bat Coronavirus Research

Details: An Analysis: Evolutionary Distance of SARS-CoV-2 and Bat Coronaviruses Studied Under the NIH-supported Research Grant to EcoHealth Alliance. The research that NIH approved under the grant to EcoHealth Alliance with a subaward to the Wuhan Institute of Virology in Wuhan, China sought to understand how animal coronaviruses, especially bat …

› Verified Just Now

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Ottavia Maria Delmonte, M.D., Ph.D. NIH: National Institute of

Details: Ottavia Delmonte, M.D., Ph.D., is a physician scientist at National Institute of Health, USA. She has been involved in translational research in primary immune deficiencies (PIDs) and disorders of immune dysregulation since joining the group of Dr. Luigi Notarangelo in 2016. She assists in the development and implementation of clinical research

› Verified Just Now

› Url: Niaid.nih.gov Go Now

› Get more:  UsaGo Now

NIH Funds New Tuberculosis Research Advancement Centers

Details: The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new grant awards to establish Tuberculosis Research Advancement Centers (TRACs). The centers will support the development of a next generation of tuberculosis (TB) researchers by providing focused mentoring and funding …

› Verified 3 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

SAVE—NIAID’s 'Avengers-Like' Research Program for Evolving …

Details: SAVE emerged from the U.S. Department of Health and Human Services’ SARS-CoV-2 Interagency Group (SIG). The repeated emergence of COVID-19-causing variants of concern made SIG leaders recognize a critical need for scientists to rapidly generate, share and assess variant data in a highly coordinated manner to enable decision-making for public

› Verified Just Now

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Monkeypox Treatment NIH: National Institute of Allergy and …

Details: Currently, there is no specific treatment approved for monkeypox virus infection. However, there are several antiviral medications used to treat smallpox and other conditions that may help patients with monkeypox infection. These antivirals include: tecovirimat or ST-246 (TPOXX); brincidofovir (Tembexa); and cidofovir (Vistide), an intravenously administered …

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Pandemic Preparedness NIH: National Institute of Allergy and

Details: The ongoing 2020 global pandemic caused by SARS-CoV-2 further has underscored the continual threat of newly emerging and re-emerging pathogens and the critical value of research in pandemic preparedness efforts. To prepare for future public health emergencies caused by infectious diseases, NIAID has developed a Pandemic Preparedness …

› Verified 6 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Apply Now for U.S.-India Fellowship Exchange Program

Details: A new Clinical Research Fellowship Exchange Program for early- and mid-career scientists aims to expand the cohort of physician-scientists that will advance clinical practice and public health in the United States and India.

› Verified 9 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine

Details: The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV). EBV is the primary cause of infectious mononucleosis and is associated with certain cancers and autoimmune diseases. …

› Verified 2 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  CancerGo Now

NIAID Scientists Advance Understanding of More Broadly …

Details: NIAID researchers designed a ferritin nanoparticle flu vaccine and tested it in people with and without immunological experience of the flu virus that caused the 1957 pandemic. The experimental vaccine prompted immune responses that suggested this kind of vaccine could provide long-lasting protection against many flu subtypes.

› Verified 5 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIAID Observes HIV Vaccine Awareness Day 2022

Details: Today marks the 25th anniversary of the first HIV Vaccine Awareness Day. Although tremendous progress has been made over the past several decades in HIV treatment and prevention, the development of a safe, effective, and durably protective vaccine to prevent HIV infection has, unfortunately, remained elusive. On this commemorative day, NIAID

› Verified 8 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Develop HIV Therapeutic Products Using NIAID Preclinical Services

Details: Take note if you are an investigator working on drug development to treat HIV and HIV-associated co-infections hepatitis B virus (HBV), hepatitis C virus (HCV), and tuberculosis (TB): our new funding opportunity announcement (FOA) Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01, Clinical Trial Not Allowed) invites you …

› Verified Just Now

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Group A Streptococcal Infections NIH: National Institute of …

Details: Types of GAS Infections. Group A streptococcal (GAS) infections can range from a mild skin infection or a sore throat to severe, life-threatening conditions. Most people are familiar with strep throat, which along with minor skin infections, is the most common form of the disease. Health experts estimate that more than 10 million mild

› Verified 6 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Hyperimmune Intravenous Immunoglobulin Does Not Improve …

Details: The main goal of the trial was to compare the health status of participants seven days after beginning treatment with hIVIG plus remdesivir with that of participants seven days after beginning treatment with remdesivir alone. The primary endpoint was an ordinal outcome with seven mutually exclusive categories ranging from no limiting symptoms

› Verified 8 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

Microbial, Immune, and Metabolic Perturbations by Antibiotics …

Details: Researchers at the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) seek healthy volunteers for a study looking at how common antibiotics affect the trillions of good microbes that live on and in our body, also known as our microbiome. What Does the Study Involve? During this study, participants may:

› Verified 4 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIAID Announces Antiviral Drug Development Awards

Details: The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

› Verified 7 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  HealthGo Now

NIAID Posts Final FY 2022 Paylines for Most Award Types

Details: We’ve set final paylines for research project grants (R01, R03, R15, R21), fellowship awards (F30, F31, F32), career development awards (K01, K08, K23, K24, K25), and small business grants (R41/R42, R43/R44) at NIAID Paylines.Fiscal year (FY) 2022 paylines cover investigator-initiated applications reviewed for the September 2021, January 2022, and …

› Verified 7 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  BusinessGo Now

Post-Doctoral Fellowship NIH: National Institute of Allergy and

Details: A post-doctoral fellowship position is currently open in the Host-Pathogen Interactions and Structural Vaccinology Section (HPISVS), Laboratory of Vaccinology and Immunology (LMIV), Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID). The goal of the HPISVS is to study the pathogenesis of

› Verified 6 days ago

› Url: Niaid.nih.gov Go Now

› Get more:  DoctorGo Now